Literature DB >> 8934536

Novel determinants of H-Ras plasma membrane localization and transformation.

B M Willumsen1, A D Cox, P A Solski, C J Der, J E Buss.   

Abstract

Although it is well-established that modification of Ras by farnesol is a critical step for its membrane association and transforming activity, the contribution of other C-terminal sequences and palmitate modification to Ras localization and function remains unclear. We have characterized H-Ras mutant proteins with alterations in the palmitoylated cysteines or in sequences flanking these residues. We found that non-palmitoylated proteins were impaired not only in membrane association but also in transforming activity. Mutations which drastically altered residues adjacent to the palmitoylated cysteine did not abolish palmitoylation. However, despite continued lipid modification the mutant proteins failed to bind to plasma membranes and instead accumulated on internal membranes and, importantly, were not transforming. Addition of an N-terminal myristoylation signal to these defective mutants, or to proteins entirely lacking the C-terminal 25 residues restored both plasma membrane association and transforming activity. Thus, H-Ras does not absolutely require prenylation or palmitoylation nor indeed its hypervariable domain in order to interact with effectors that ultimately cause transformation. However, in this native state, the C-terminus appears to provide a combination of lipids and a previously unrecognized signal for specific plasma membrane targeting that are essential for the correct localization and biological function of H-Ras.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8934536

Source DB:  PubMed          Journal:  Oncogene        ISSN: 0950-9232            Impact factor:   9.867


  27 in total

1.  Association of prenylated proteins with the plasma membrane and the inner nuclear membrane is mediated by the same membrane-targeting motifs.

Authors:  H Hofemeister; K Weber; R Stick
Journal:  Mol Biol Cell       Date:  2000-09       Impact factor: 4.138

2.  A cell-specific, prenylation-independent mechanism regulates targeting of type II RACs.

Authors:  Meirav Lavy; Keren Bracha-Drori; Hasana Sternberg; Shaul Yalovsky
Journal:  Plant Cell       Date:  2002-10       Impact factor: 11.277

Review 3.  Targeting RAS Membrane Association: Back to the Future for Anti-RAS Drug Discovery?

Authors:  Adrienne D Cox; Channing J Der; Mark R Philips
Journal:  Clin Cancer Res       Date:  2015-04-15       Impact factor: 12.531

4.  K-ras4B and prenylated proteins lacking "second signals" associate dynamically with cellular membranes.

Authors:  John R Silvius; Pinkesh Bhagatji; Rania Leventis; Donato Terrone
Journal:  Mol Biol Cell       Date:  2005-10-19       Impact factor: 4.138

Review 5.  In vitro and cellular assays for palmitoyl acyltransferases using fluorescent lipidated peptides.

Authors:  Charles E Ducker; Jeremiah M Draper; Zuping Xia; Charles D Smith
Journal:  Methods       Date:  2006-10       Impact factor: 3.608

6.  Discovery and characterization of inhibitors of human palmitoyl acyltransferases.

Authors:  Charles E Ducker; Lindsay K Griffel; Ryan A Smith; Staci N Keller; Yan Zhuang; Zuping Xia; John D Diller; Charles D Smith
Journal:  Mol Cancer Ther       Date:  2006-07       Impact factor: 6.261

7.  LKB1, a novel serine/threonine protein kinase and potential tumour suppressor, is phosphorylated by cAMP-dependent protein kinase (PKA) and prenylated in vivo.

Authors:  S P Collins; J L Reoma; D M Gamm; M D Uhler
Journal:  Biochem J       Date:  2000-02-01       Impact factor: 3.857

Review 8.  Dynamic palmitoylation and the role of DHHC proteins in T cell activation and anergy.

Authors:  Nadejda Ladygina; Brent R Martin; Amnon Altman
Journal:  Adv Immunol       Date:  2011       Impact factor: 3.543

9.  Molecular Mechanism for Isoform-Selective Inhibition of Acyl Protein Thioesterases 1 and 2 (APT1 and APT2).

Authors:  Sang Joon Won; Dahvid Davda; Kristin J Labby; Sin Ye Hwang; Rachel Pricer; Jaimeen D Majmudar; Kira A Armacost; Laura A Rodriguez; Christina L Rodriguez; Fei San Chong; Kristopher A Torossian; Jasmine Palakurthi; Edward S Hur; Jennifer L Meagher; Charles L Brooks; Jeanne A Stuckey; Brent R Martin
Journal:  ACS Chem Biol       Date:  2016-10-31       Impact factor: 5.100

10.  2-Bromopalmitate and 2-(2-hydroxy-5-nitro-benzylidene)-benzo[b]thiophen-3-one inhibit DHHC-mediated palmitoylation in vitro.

Authors:  Benjamin C Jennings; Marissa J Nadolski; Yiping Ling; Meredith Beckham Baker; Marietta L Harrison; Robert J Deschenes; Maurine E Linder
Journal:  J Lipid Res       Date:  2008-09-30       Impact factor: 5.922

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.